Stockreport

Immunic to Host MS R&D Day and Participate in Investor Conferences in April [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF molecule therapies for chronic inflammatory and autoimmune diseases, today announced that it will host a Multiple Sclerosis (MS) Research and Development (R&D) Day and p [Read more]